News | August 23, 2010

Topex Sells Skin Cancer Business

August 23, 2010 - The radiation therapy skin cancer business of Topex Inc. is being sold to Sensus Healthcare. Sensus will take over sales of the low-energy SRT 100 superficial radiotherapy treatment system.

Since TOPEX received U.S. Food and Drug Administration (FDA) clearance for the system in 2007, many systems have been operating worldwide at hospital radiation oncology centers and in dermatology and veterinary oncology practices for the treatment of skin cancer.

The low-energy superficial radiotherapy system provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers, especially primary lesions requiring difficult or extensive surgery with sensitive structures in the head and neck regions, such as the fold in the nose, eyelids, lips, corner of the mouth, and the lining of the ear, that would otherwise lead to a less-than-desirable cosmetic outcome. This treatment procedure does not require the use of anesthetics and eliminates the need for skin grafting.

The incidence of skin cancer has steadily increased over the past 75 years. During the 1930s, one in 1,500 developed skin cancer. In 1960, the rate had risen to one in 600 and in 2000, the rate increased to one in 66. The National Cancer Institute estimates that one out of five is now at risk for developing some form of skin cancer during their lifetime.

Increased exposure to the sun without skin protection and a decreasing natural ozone layer are cited as the chief causes of this increase. It is estimated that up to 1.3 million new skin cancer cases are diagnosed annually in the United States and more than 2.5 million worldwide. This is projected to increase at a rate of four percent each year.

For more information: www.sensushealthcare.com

Related Content

RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...